energizing my position today...
DUBLIN--(BUSINESS WIRE)--June 07, 2013--
Research and Marketshas announced the addition of the "Malignant Glioma - Pipeline Review, H1 2013" report to their offering.
- A snapshot of the global therapeutic scenario for Malignant Glioma.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Malignant Glioma pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
-- Boehringer Ingelheim GmbH
-- F. Hoffmann-La Roche Ltd.
-- Amgen Inc.
-- AstraZeneca PLC
-- Eli Lilly and Company
-- Eisai Co., Ltd.
-- Oncolytics Biotech Inc.
-- Cytomedix, Inc.
-- Nerviano Medical Sciences S.r.l.
-- BioNumerik Pharmaceuticals, Inc.
-- Biovista Inc.
-- EirGen Pharma Ltd.
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: Research and Markets
Laura Wood, Senior Manager.
Sentiment: Strong Buy